| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inozyme Pharma, Inc. | Director | Common Stock | 0 | $0 | $4.00 | 01 Jul 2025 | Direct |
| Inozyme Pharma, Inc. | Director | Stock Option (Right to Buy) | 0 | 01 Jul 2025 | Direct | ||
| IVERIC bio, Inc. | Director | Common Stock | 0 | $39.45 | 11 Jul 2023 | Direct | |
| IVERIC bio, Inc. | Director | Restricted Stock Units | 0 | 11 Jul 2023 | Direct | ||
| IVERIC bio, Inc. | Director | Stock Option (Right to Buy) | 0 | $10.03 | 11 Jul 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INZY | Inozyme Pharma, Inc. | 01 Jul 2025 | 3 | -$1,695,704 | 4 | Director | 03 Jul 2025, 19:07 |
| INZY | Inozyme Pharma, Inc. | 15 May 2025 | 4 | +$154,085 | 4 | Director | 20 May 2025, 16:00 |
| INZY | Inozyme Pharma, Inc. | 18 Jun 2024 | 1 | $0 | 4 | Director | 20 Jun 2024, 16:09 |
| /report/000110465923080679-bolte-axel-2023-07-11 | IVERIC bio, Inc. | 11 Jul 2023 | 8 | $0 | 4 | Director | 13 Jul 2023, 13:55 |
| INZY | Inozyme Pharma, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:05 |
| /report/000141093923000089-bolte-axel-2023-05-17 | IVERIC bio, Inc. | 17 May 2023 | 1 | $0 | 4 | Director | 19 May 2023, 17:55 |
| /report/000141093923000077-bolte-axel-2023-05-11 | IVERIC bio, Inc. | 11 May 2023 | 2 | $0 | 4 | Director | 15 May 2023, 16:51 |
| INZY | Inozyme Pharma, Inc. | 01 May 2023 | 1 | $0 | 4 | Director | 03 May 2023, 08:40 |
| INZY | Inozyme Pharma, Inc. | 31 Mar 2023 | 1 | +$10,621 | 4 | Director | 04 Apr 2023, 08:40 |
| INZY | Inozyme Pharma, Inc. | 30 Sep 2022 | 1 | +$7,558 | 4 | Chief Executive Officer, Director | 04 Oct 2022, 08:00 |
| /report/000141093922000069-bolte-axel-2022-05-11 | IVERIC bio, Inc. | 11 May 2022 | 4 | $0 | 4 | Director | 13 May 2022, 18:05 |
| INZY | Inozyme Pharma, Inc. | 19 Apr 2022 | 1 | +$249,998 | 4 | Chief Executive Officer, Director | 20 Apr 2022, 16:05 |
| INZY | Inozyme Pharma, Inc. | 24 Feb 2022 | 1 | $0 | 4 | Chief Executive Officer, Director | 28 Feb 2022, 06:47 |
| INZY | Inozyme Pharma, Inc. | 24 Jun 2021 | 3 | +$65,446 | 4 | Chief Executive Officer, Director | 25 Jun 2021, 07:58 |
| /report/000110465921070097-bolte-axel-2021-05-19 | IVERIC bio, Inc. | 19 May 2021 | 2 | $0 | 4 | Director | 20 May 2021, 19:51 |